Effect of prophylactic caffeine in the treatment of apnea in very low birth weight infants: a meta-analysis

References

• Erickson G, Dobson NR, Hunt CE. Immature control of breathing and apnea of prematurity: the known and unknown. J Perinatol. 2021;41(9):2111–2123.
   PubMed Web of Science ®Google Scholar
• Montenegro BL, Amberson M, Veit L, et al. Economics of home monitoring for apnea in late preterm infants. Respir Care. 2017;62(1):42–48.
   PubMed Web of Science ®Google Scholar
• Schoen K, Yu T, Stockmann C, et al. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity. Paediatr Drugs. 2014;16(2):169–177.
   PubMed Web of Science ®Google Scholar
• Alhersh E, Abushanab D, Al-Shaibi S, et al. Caffeine for the treatment of apnea in the neonatal intensive care unit: a systematic overview of meta-analyses. Paediatr Drugs. 2020;22(4):399–408.
   PubMed Web of Science ®Google Scholar
• Pergolizzi J, Kraus A, Magnusson P, et al. Treating apnea of prematurity. Cureus. 2022;14(1):e21783.
   PubMed Web of Science ®Google Scholar
• Henderson-Smart DJ, De Paoli AG. Prophylactic methylxanthine for prevention of apnoea in preterm infants. Cochrane Database Syst Rev. 2010;2010(12):Cd000432.
   PubMedGoogle Scholar
• Nylander Vujovic S, Nava C, Johansson M, et al. Confounding biases in studies on early-versus late-caffeine in preterm infants: a systematic review. Pediatr Res. 2020;88(3):357–364.
   PubMed Web of Science ®Google Scholar
• Kua KP, Lee SW. Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates. Br J Clin Pharmacol. 2017;83(1):180–191.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Altman DG, Gøtzsche PC, et al. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
   PubMed Web of Science ®Google Scholar
• Amaro CM, Bello JA, Jain D, et al. Early caffeine and weaning from mechanical ventilation in preterm infants: a randomized, placebo-controlled trial. J Pediatr. 2018;196:52–57.
   PubMed Web of Science ®Google Scholar
• Armanian AM, Iranpour R, Faghihian E, et al. Caffeine administration to prevent apnea in very premature infants. Pediatr Neonatol. 2016;57(5):408–412.
   PubMed Web of Science ®Google Scholar
• Davis PG, Schmidt B, Roberts RS, et al. Caffeine for apnea of prematurity trial: benefits may vary in subgroups. J Pediatr. 2010;156(3):382–387.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112–2121.
   PubMed Web of Science ®Google Scholar
• Elmowafi M, Mohsen N, Nour I, et al. Prophylactic versus therapeutic caffeine for apnea of prematurity: a randomized controlled trial. J Matern Fetal Neonatal Med. 2022;35(25):6053–6061.
   PubMed Web of Science ®Google Scholar
• Fakoor Z, Makooie AA, Joudi Z, et al. The effect of venous caffeine on the prevention of apnea of prematurity in the very preterm infants in the neonatal intensive care unit of Shahid Motahhari Hospital, Urmia, during a year. J Adv Pharm Technol Res. 2019;10(1):16–19.
   PubMed Web of Science ®Google Scholar
• Iranpour R, Armanian AM, Miladi N, et al. Effect of prophylactic caffeine on noninvasive respiratory support in preterm neonates weighing 1250–2000 g: a randomized controlled trial. Arch Iran Med. 2022;25(2):98–104.
   PubMed Web of Science ®Google Scholar
• Kobaly K, Mandel SJ. Hyperthyroidism and pregnancy. Endocrinol Metab Clin North Am. 2019;48(3):533–545.
   PubMed Web of Science ®Google Scholar
• Kou C, Han D, Li Z, et al. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea. Minerva Pediatr. 2020;72(2):95–100.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao J. PV1: gatekeeper of endothelial permeability. Am J Respir Cell Mol Biol. 2020;63(4):413–414.
   PubMed Web of Science ®Google Scholar
• Zulqarnain A, Hussain M, Suleri KM, et al. Comparison of caffeine versus theophylline for apnea of prematurity. Pak J Med Sci. 2019;35(1):113–116.
   PubMed Web of Science ®Google Scholar
• Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome – 2019 update. Neonatology. 2019;115(4):432–450.
   PubMed Web of Science ®Google Scholar
• Levitt GA, Mushin A, Bellman S, et al. Outcome of preterm infants who suffered neonatal apnoeic attacks. Early Hum Dev. 1988;16(2–3):235–243.
   PubMed Web of Science ®Google Scholar
• Dobson NR, Patel RM, Smith PB, et al. Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants. J Pediatr. 2014;164(5):992–998.e993.
   PubMed Web of Science ®Google Scholar
• Lodha A, Seshia M, McMillan DD, et al. Association of early caffeine administration and neonatal outcomes in very preterm neonates. JAMA Pediatr. 2015;169(1):33–38.
   PubMed Web of Science ®Google Scholar
• Eichenwald EC, Watterberg KL, Aucott S, et al. Apnea of prematurity. Pediatrics. 2016;137(1):e20153757.
   Web of Science ®Google Scholar
• Kilicdag H, Daglioglu YK, Erdogan S, et al. Effects of caffeine on neuronal apoptosis in neonatal hypoxic-ischemic brain injury. J Matern Fetal Neonatal Med. 2014;27(14):1470–1475.
   PubMed Web of Science ®Google Scholar
• Park HW, Lim G, Chung SH, et al. Early caffeine use in very low birth weight infants and neonatal outcomes: a systematic review and meta-analysis. J Korean Med Sci. 2015;30(12):1828–1835.
   Google Scholar
• Borszewska-Kornacka MK, Hożejowski R, Rutkowska M, et al. Shifting the boundaries for early caffeine initiation in neonatal practice: results of a prospective, multicenter study on very preterm infants with respiratory distress syndrome. PLoS One. 2017;12(12):e0189152.
   PubMed Web of Science ®Google Scholar
• Abu-Shaweesh JM, Martin RJ. Caffeine use in the neonatal intensive care unit. Semin Fetal Neonatal Med. 2017;22(5):342–347.
   PubMed Web of Science ®Google Scholar
• Geetha O, Rajadurai VS, Anand AJ, et al. New BPD-prevalence and risk factors for bronchopulmonary dysplasia/mortality in extremely low gestational age infants ≤28 weeks. J Perinatol. 2021;41(8):1943–1950.
   PubMed Web of Science ®Google Scholar
• Patel RM, Leong T, Carlton DP, et al. Early caffeine therapy and clinical outcomes in extremely preterm infants. J Perinatol. 2013;33(2):134–140.
   PubMed Web of Science ®Google Scholar
• Ogden BE, Murphy SA, Saunders GC, et al. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis. 1984;130(5):817–821.
   PubMedGoogle Scholar
• Weichelt U, Cay R, Schmitz T, et al. Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine. Eur Respir J. 2013;41(4):966–973.
   PubMed Web of Science ®Google Scholar
• Tiwari KK, Chu C, Couroucli X, et al. Differential concentration-specific effects of caffeine on cell viability, oxidative stress, and cell cycle in pulmonary oxygen toxicity in vitro. Biochem Biophys Res Commun. 2014;450(4):1345–1350.
   PubMed Web of Science ®Google Scholar
• Chen J, Jin L, Chen X. Efficacy and safety of different maintenance doses of caffeine citrate for treatment of apnea in premature infants: a systematic review and meta-analysis. Biomed Res Int. 2018;2018:9061234.
   PubMed Web of Science ®Google Scholar
• Soloveychik V, Bin-Nun A, Ionchev A, et al. Acute hemodynamic effects of caffeine administration in premature infants. J Perinatol. 2009;29(3):205–208.
   PubMed Web of Science ®Google Scholar
• Manku MS, Horrobin DF. Chloroquine, quinine, procaine, quinidine, tricyclic antidepressants, and methylxanthines as prostaglandin agonists and antagonists. Lancet. 1976;2(7995):1115–1117.
   PubMed Web of Science ®Google Scholar
• Bhatt-Mehta V, Schumacher RE. The effect of ibuprofen and caffeine prophylaxis on retinopathy of prematurity. JAAPOS. 2021;25(5):272.e271–272.e273.
   Google Scholar
• Aranda JV, Beharry K, Valencia GB, et al. Caffeine impact on neonatal morbidities. J Matern Fetal Neonatal Med. 2010;23(Suppl 3):20–23.
   PubMedGoogle Scholar
• Park HW, Lim G, Chung SH, et al. Early caffeine use in very low birth weight infants and neonatal outcomes: a systematic review and meta-analysis. J Korean Med Sci. 2015;30(12):1828–1835.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893–1902.
   PubMed Web of Science ®Google Scholar
• Gounaris A, Kokori P, Varchalama L, et al. Theophylline and gastric emptying in very low birthweight neonates: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2004;89(4):F297–299.
   PubMed Web of Science ®Google Scholar
• Atik A, Harding R, De Matteo R, et al. Caffeine for apnea of prematurity: effects on the developing brain. Neurotoxicology. 2017;58:94–102.
   PubMed Web of Science ®Google Scholar